xamoterol has been researched along with oxidopamine in 1 studies
| Studies (xamoterol) | Trials (xamoterol) | Recent Studies (post-2010) (xamoterol) | Studies (oxidopamine) | Trials (oxidopamine) | Recent Studies (post-2010) (oxidopamine) |
|---|---|---|---|---|---|
| 269 | 80 | 17 | 8,630 | 6 | 2,407 |
| Protein | Taxonomy | xamoterol (IC50) | oxidopamine (IC50) |
|---|---|---|---|
| Glyceraldehyde-3-phosphate dehydrogenase | Homo sapiens (human) | 8 | |
| DNA repair protein RAD52 homolog | Homo sapiens (human) | 0.779 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hoizey, G; Millart, H; Robinet, A | 1 |
1 other study(ies) available for xamoterol and oxidopamine
| Article | Year |
|---|---|
PI 3-kinase, protein kinase C, and protein kinase A are involved in the trigger phase of beta1-adrenergic preconditioning.
Topics: Adrenergic beta-Agonists; Androstadienes; Animals; Blotting, Western; Chromones; Coronary Circulation; Cyclic AMP-Dependent Protein Kinases; Enzyme Inhibitors; Heart Rate; Ischemic Preconditioning, Myocardial; Isoquinolines; Male; Morpholines; Myocardial Reperfusion Injury; Myocardium; Oxidopamine; Perfusion; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase C; Rats; Rats, Wistar; Sulfonamides; Wortmannin; Xamoterol | 2005 |